Genetic immunization with the free human chorionic gonadotropin β subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice

Laboratory Investigation

Volumn 76, Issue 6, 1997, Pages 859-871

  Geissler, Michael ^a,b   Wands, Gregory ^c   Gesien, Annette ^a,b   De La Monte, Suzanne ^a,b   Bellet, Dominique ^d,e   Wands, Jack R ^a,b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Ares Advanced Technology   (United States)

^d FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CHORIONIC GONADOTROPIN RECEPTOR; NEUTRALIZING ANTIBODY; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DNA; FEMALE; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA;

EID: 0031008557     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Acevedo HF, Tong JY, and Hartsock RJ (1995). Human chorionic gonadotropin b subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76:1467-1475.
2. Bellet DH, Ozturk M, Bidart JM, Bohuon CJ, and Wands JR (1986). Sensitive and specific assay for human chorionic gonadotropin (hCG) based on anti-peptide and anti-hCG monoclonal antibodies: Construction and clinical implications. J Clin Endocrinol Metab 63:1319-1327.
3. Bidart JM, Bellet DH, Alberici GF, Besien VF, and Bohuon C (1987). The immune response to a synthetic peptide analogous to the 109-145 beta hCG carboxyl-terminus is directed against two major and two minor regions. Mol Immunol 24:339-345.
4. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, and Van Pel A (1994). Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365.
5. Boorstein WR, Vamvakopoulos NC, and Fiddes JC (1982). Human chorionic gonadotropin beta-subunit is encoded by at least eight genes arranged in tandem and inverted pairs. Nature 300:419-422.
6. Bright RK, Shearer MH, and Kennedy RC (1995). Nucleic acid vaccination against virally induced tumors. Ann NY Acad Sci 772:241-251.
7. Conry RM, LoBuglio AF, Kantor J, Schlom J, Loechel F, Moore SE, Sumerel LA, Barlow DL, Abrams S, and Curiel DT (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 54:1164-1168.
8. Dranoff G, Jaffee E, Lazenby A, Golumbeck P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, and Mulligan R (1993). Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539-3543.
9. Ertl HC and Xiang Z (1996). Novel vaccine approaches. J Immunol 156:3579-3582.
10. Feng W, Matzuk MM, Mountjoy K, Bedows E, Ruddon RW, and Boime I (1995). The asparagine-linked oligosaccharides of the human chorionic gonadotropin beta subunit facilitate correct disulfide bond pairing. J Biol Chem 270:11851-11859.
11. Fiddes JC and Goodman HM (1980). The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3′-untranslated region. Nature 286:684-687.
12. Geissler M, Gesien A, Tokushige K, and Wands JR (1997). Enhancement of cellular and humoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids. J Immunol 158:1231-1237.
13. Gillott DJ, Iles RK, and Chard T (1996). The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 73:323-326.
14. Hoermann R, Gerbes AL, Spoettl G, Jungst D, and Mann K (1992). Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors. Cancer Res 52:1520-1524.
15. Housseau F, Rouas FN, Benifla JL, Marcillac I, Roy M, Troalen F, Fernandez H, Prapotnich D, Valencien G, Bougaran J, and Bellet D (1995). Reaction of peripheral-blood lymphocytes to the human chorionic gonadotropin beta sub-unit in patients with productive tumors. Int J Cancer 63:633-638.
16. Huth JR, Mountjoy K, Perini F, Bedows E, and Ruddon RW (1992). Domain-dependent protein folding is indicated by the intracellular kinetics of disulfide bond formation of human chorionic gonadotropin beta subunit. J Biol Chem 267: 21396-21403.
17. Iles RK, Oliver RT, Kitau M, Walker C, and Chard T (1987). In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br J Cancer 55:623-626.
18. Iles RK, Purkis PE, Whitehead PC, Oliver RT, Leigh I, and Chard T (1990). Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine "normal" and malignant epithelial cells. Br J Cancer 61:663-666.
19. Irvine KR, Rao JB, Rosenberg SA, and Restifo NP (1996). Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156:238-245.
20. Lazar V, Diez SG, Laurent A, Giovangrandi Y, Radvanyi F, Chopin D, Bidart JM, Bellet D, and Vidaud M (1995). Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas. Cancer Res 55:3735-3738.
21. Madersbacher S, Klieber R, Mann K, Marth C, Tabarelli M, Wick G, and Berger P (1992). Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem 38:370-376.
22. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhomme C, Rougier P, and Bellet D (1992). Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 52:3901-3907.
23. Moudgil KM and Sercarz EE (1994). Can antitumor immune responses discriminate between self and nonself? Immunol Today 15:353-355.
24. Moutzoauris G, Yannopoulos D, and Barbatis C (1993). Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker for aggressive disease and resistance to chemotherapy? Br J Urol 72:807-809.
25. Mukherjee K and Das S (1904). A placental glycoprotein: Human chorionic gonadotropin as a growth stimulant of murine tumor cells. IRCS Med Sci 12:1101-1102.
26. Nanda NK and Sercarz EE (1995). Induction of anti-self-immunity to cure cancer. Cell 82:13-17.
27. Nishimura R, Koizumi T, Morisue K, Yamanaka N, Lalwani R, Yoshimura M, Nakagawa T, Shii K, Hasegawa K, and Baba S (1995). Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. Cancer Res 55:1479-1484.
28. O'Connor JF, Birkens S, and Lustbader JW (1994). Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: Impact on clinical measurement. Endocr Rev 15:650-683.
29. Ohlsson R (1987). Growth factors, proto-oncogenes and human placental development. Cell Differ Develop 28:1-16.
30. Ozturk M, Bellet D, Isselbacher KJ, and Wands J (1987). Ectopic beta-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): Isolation and immunochemical characterization. Endocrinology 120:559-566.
31. Ozturk M, Bellet D, Manil L, Hennen G, Frydman R, and Wands J (1987). Physiological studies of human chorionic gonadotropin (hCG), alpha hCG, and beta hCG as measured by specific monoclonal immunoradiometric assays. Endocrinology 120:549-558.
32. Ozturk M, Berkowitz R, Goldstein D, Bellet D, and Wands JR (1988). Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol 158:193-198.
33. Pierce JG and Parsons TF (1981). Glycoprotein hormones: Structure and function. Annu Rev Biochem 50:465-495.
34. Policastro P, Ovitt CE, Hoshina M, Fukuoka H, Boothby MR, and Boime I (1983). The beta subunit of human chorionic gonadotropin is encoded by multiple genes. J Biol Chem 258:11492-11499.
35. Regelson W (1995). Have we found the "definitive cancer biomarker"? Cancer 76:1299-1301.
36. Tang D, DeVit M, and Johnston SA (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
37. Toes REM, Blom RJJ, Offringa R, Kast WM, and Melief CJM (1996). Enhanced tumor outgrowth after peptide vaccination. J Immunol 156:3911-3918.
38. Van Beek WP, Smets LA, and Emmelot P (1973). Increased sialic acid density in surface glycoprotein of transformed and malignant cells: A general phenomenon? Cancer Res 33:92-100.
39. Wang B, Merva M, Dang K, Ugen KE, Williams WV, and Weiner DB (1995). Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum Gene Ther 6:407-418.
40. Whalen RG and Davis HL (1995). DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin Immunol Immunopathol 75:1-12.
41. Williams WV, Boyer JD, Merva M, Livolsi V, Wilson D, Wang B, and Weiner DB (1993). Genetic infection induces protective in vivo immune responses. DNA Cell Biol 12:675-683.
42. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, and Feigner PL (1990). Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
43. Xiang Z and Ertl HC (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.